Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...

Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock fell Monday after the U.S. Food and Drug Administration accepted the company’s Biologics License Application (BLA) for INO-3107 but raised concerns tied ...

Inovio Pharmaceuticals ( ($INO) ) has provided an announcement. On December 29, 2025, INOVIO announced that the U.S. Food and Drug Administration ...

Investing.com -- Inovio Pharmaceuticals Inc (NASDAQ:INO) stock plunged 21% Monday after the FDA raised concerns about the company’s accelerated approval pathway for its RRP treatment candidate.

Shares of Inovio Pharmaceuticals Inc. INO cratered 24.45% to $1.73 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling ...

Shares of Inovio Pharmaceuticals Inc. INO slipped 4.44% to $2.15 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising ...

Pomerantz LLP is investigating claims on behalf of investors of Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] ...

ROHM signs strategic partnership with India’s Tata Electronics to develop and manufacture semiconductors in India.

Summary • Inovio Pharmaceuticals shares fell 21.1% to $1.81 amid market activity without a clear catalyst.• The FDA accepted ...

“To us, flea markets are the perfect antidote to the steering algorithms of the online world. They are unorganised, cluttered ...

Inovalis Real Estate Investment Trust (the “REIT”) (TSX: INO.UN) today announced the closing of the sale of the Baldi property for €14.0 million ($22.9 million). The 124,000 square foot office and ...

The Victoires de la Musique have revealed the full list of nominees for this 41st edition. While some faces are becoming ...